Policyholder Services

Will OMIC cover me for the intravitreal injection of kenalog?

Yes. Although the use of Kenalog has been FDA approved only for intramuscular administration, intra-articular administration, and administration within a tendon sheath, this steroid is routinely used on an off-label basis by ophthalmologists. Provided that the indication of the injection (whether subconjunctivally, subTenon, into the lid, or intravitreally) is appropriate and the physician is properly trained and experienced, OMIC will extend coverage for the insured’s use of Kenalog.